These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28197685)

  • 1. Test-retest measurements of dopamine D
    Kaller S; Rullmann M; Patt M; Becker GA; Luthardt J; Girbardt J; Meyer PM; Werner P; Barthel H; Bresch A; Fritz TH; Hesse S; Sabri O
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1025-1032. PubMed ID: 28197685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic Modelling and Test-Retest Reproducibility for the Dopamine D
    Bertoglio D; Verhaeghe J; Miranda A; Wyffels L; Stroobants S; Dominguez C; Munoz-Sanjuan I; Skinbjerg M; Liu L; Staelens S
    Mol Imaging Biol; 2021 Apr; 23(2):208-219. PubMed ID: 33179158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test-retest reproducibility of binding parameters in humans with 11C-LY2795050, an antagonist PET radiotracer for the κ opioid receptor.
    Naganawa M; Zheng MQ; Henry S; Nabulsi N; Lin SF; Ropchan J; Labaree D; Najafzadeh S; Kapinos M; Tauscher J; Neumeister A; Carson RE; Huang Y
    J Nucl Med; 2015 Feb; 56(2):243-8. PubMed ID: 25593119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test-retest reliability of the novel 5-HT1B receptor PET radioligand [11C]P943.
    Saricicek A; Chen J; Planeta B; Ruf B; Subramanyam K; Maloney K; Matuskey D; Labaree D; Deserno L; Neumeister A; Krystal JH; Gallezot JD; Huang Y; Carson RE; Bhagwagar Z
    Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):468-77. PubMed ID: 25427881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Evaluation of an Adenosine A
    Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Zhou X; de Vries EFJ; Elsinga PH; Ishiwata K; Toyohara J
    J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
    Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
    Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
    Kim JS; Ichise M; Sangare J; Innis RB
    J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic evaluation of [
    Kramer V; Juri C; Riss PJ; Pruzzo R; Soza-Ried C; Flores J; Hurtado A; Rösch F; Chana-Cuevas P; Amaral H
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1927-1937. PubMed ID: 31788709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo Evaluation of
    Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
    J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
    [No Abstract]   [Full Text] [Related]  

  • 11. Age-dependent decline of dopamine D1 receptors in human brain: a PET study.
    Wang Y; Chan GL; Holden JE; Dobko T; Mak E; Schulzer M; Huser JM; Snow BJ; Ruth TJ; Calne DB; Stoessl AJ
    Synapse; 1998 Sep; 30(1):56-61. PubMed ID: 9704881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling [
    Laurencin C; Lancelot S; Gobert F; Redouté J; Mérida I; Iecker T; Liger F; Irace Z; Greusard E; Lamberet L; Bars DL; Costes N; Ballanger B
    Neuroimage; 2021 Oct; 240():118328. PubMed ID: 34224852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is dopamine D1 receptor availability related to social behavior? A positron emission tomography replication study.
    Plavén-Sigray P; Matheson GJ; Gustavsson P; Stenkrona P; Halldin C; Farde L; Cervenka S
    PLoS One; 2018; 13(3):e0193770. PubMed ID: 29543812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of striatal and extrastriatal dopamine D1 receptor binding potential with [11C]NNC 112 in humans: validation and reproducibility.
    Abi-Dargham A; Martinez D; Mawlawi O; Simpson N; Hwang DR; Slifstein M; Anjilvel S; Pidcock J; Guo NN; Lombardo I; Mann JJ; Van Heertum R; Foged C; Halldin C; Laruelle M
    J Cereb Blood Flow Metab; 2000 Feb; 20(2):225-43. PubMed ID: 10698059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of scan-time shortening on the
    Matsunaga K; Tonomura M; Abe K; Shimosegawa E
    Ann Nucl Med; 2023 Apr; 37(4):227-237. PubMed ID: 36656501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproducibility of PET measurement for presynaptic dopaminergic functions using L-[β-(11)C]DOPA and [(18)F]FE-PE2I in humans.
    Suzuki M; Ito H; Kodaka F; Takano H; Kimura Y; Fujiwara H; Sasaki T; Takahata K; Nogami T; Nagashima T; Nengaki N; Kawamura K; Zhang MR; Varrone A; Halldin C; Okubo Y; Suhara T
    Nucl Med Commun; 2014 Mar; 35(3):231-7. PubMed ID: 24468851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study.
    Jucaite A; Forssberg H; Karlsson P; Halldin C; Farde L
    Neuroscience; 2010 Apr; 167(1):104-10. PubMed ID: 20109534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproducibility of the distribution of carbon-11-SCH 23390, a dopamine D1 receptor tracer, in normal subjects.
    Chan GL; Holden JE; Stoessl AJ; Doudet DJ; Wang Y; Dobko T; Morrison KS; Huser JM; English C; Legg B; Schulzer M; Calne DB; Ruth TJ
    J Nucl Med; 1998 May; 39(5):792-7. PubMed ID: 9591577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurement of cortical dopamine d1 receptor binding with 11C[SCH23390]: a test-retest analysis.
    Hirvonen J; Någren K; Kajander J; Hietala J
    J Cereb Blood Flow Metab; 2001 Oct; 21(10):1146-50. PubMed ID: 11598491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756.
    Abi-Dargham A; Simpson N; Kegeles L; Parsey R; Hwang DR; Anjilvel S; Zea-Ponce Y; Lombardo I; Van Heertum R; Mann JJ; Foged C; Halldin C; Laruelle M
    Synapse; 1999 May; 32(2):93-109. PubMed ID: 10231129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.